Pharmaceutical Intermediate Purity Aripiprazole Raw Powder 129722-12-9 Aripiprazole

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: HRK-Aripiprazole
• Product Name: Aripiprazole
• Appearance: White Powder
• Active Ingredient: Aripiprazole
• Sample: Aripiprazole Avaliable
• Einecs No: 603-355-5
• CAS No: 129722-12-9
• Mf: C23h27cl2n3o2
• MW: 448.39
• Certificate: GMP ISO USP Bp
• Test: HPLC
• Grade Standard: Pharmaceutical Grade
• Type of Product: Cosmetic
• Assay: 99.9% Min
• Storage: Cool Dry Place
• Shelf Life: 2 Years Proper Storage
• Transport Package: 1kg Per Bag
• Specification: 99% min Aripiprazole
• Trademark: Henrikang
• Origin: Shaanxi China
• Production Capacity: 5000kg/Year

Product Description

Pharmaceutical Intermediate Purity Aripiprazole Raw Powder 129722-12-9 Aripiprazole

Product Name	Pharmaceutical Intermediate Aripiprazole Raw Powder 129722-12-9 Aripiprazole
CAS NO	129722-12-
Appearance	White Powder
Molecular Formula	C23H27Cl2N3O2
Storage	Keep in a cool, dry, dark location
Shelf Life	24 months when properly stored

Pharmaceutical Intermediate Aripiprazole Raw Powder 129722-12-9 Aripiprazole is a new highly fat-soluble quinolindone derivative with pharmacological characteristics as a postsynaptic dopamine D2 receptor antagonist and a presynaptic dopamine D2 receptor agonist. It also has agonistic effects on D1, D3 and D4 receptors; it has a dual effect of partial receptor antagonism or activation on 5-HT1A receptors; and a complete antagonistic effect on 5-HT2A receptors. This feature is different from the first generation and atypical antipsychotic drugs, i.e., the second generation antipsychotic drugs, and is therefore called dopamine system stabilizers or third generation antipsychotic drugs. Since the last century, it is mainly used clinically for the treatment of schizophrenia, schizoaffective psychosis and other psychotic disorders. According to the literature, aripiprazole has shown significant efficacy on positive and negative symptoms of schizophrenia and on anxiety, depression, and cognitive function, while having a higher safety profile.